• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Gilead targets 'large-scale' HIV drugs counterfeiting scheme as judge orders...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 29, 2022 at 07:42: PM
via As Gilead Sciences continues its efforts to crack down on alleged fake HIV drugs across the nation, the company has scored a legal win for another recently uncovered elaborate scheme to sell counterfeit drugs.

article source
 




Top Bottom
Back
Quote